Is Rhythm Pharmaceuticals, Inc. (RYTM) a Buy, Sell, or Hold?
NASDAQ : RYTM
Rhythm Pharmaceuticals, Inc. — Analyst Ratings
$99.25 USD
-$6.49 (-6.14%)
- Volume
- 435.36K
- Average Volume
- 818K
- Market Capitalization
- $6.81B
- P/E Ratio
- -31.71
- Dividend Yield
- 0.00%
- Price Target
- $142.00
- Year High
- $122.20
- Year Low
- $74.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.17
Analyst Consensus Summary
Consensus Rating
Strong Sell
21 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-30.1%
vs Current Price
Price Target
$142.00
Average TargetPrice Target Range
Lowest Target
$125.00
-20.6% DOWNSIDE
Average Target
$142.00
Median Estimate
Highest Target
$155.00
-36.0% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 21
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 21 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Canaccord Genuity | Whitney Ijem | $151 | $89.7 | 2026-06-16 06:36 AM | 68.3% |
| Stifel Nicolaus | Paul Matteis | $133 | $94.7336 | 2026-06-15 09:31 AM | 40.4% |
| Jefferies | Dennis Ding | $125 | $89.56 | 2026-03-03 05:11 PM | 39.6% |
| Stifel Nicolaus | Paul Matteis | $131 | $99.54 | 2026-02-26 12:21 PM | 31.6% |
| RBC Capital | Lisa Walter | $145 | $101.3 | 2026-02-18 04:10 PM | 43.1% |